论文部分内容阅读
对象为我院1984年1月～1998年10月收治的26例妊娠合并甲亢的患者,根据临床表现及TT_4水平将患者分为轻、中和重度。轻度在医生严密监测下暂停抗甲状腺药物;对中度及其以上者给予抗甲状腺药物治疗。待病情控制后逐渐减量,以每1～2周递减1/3～1/2量,至控制症状的最小剂量为维持量,使孕妇处于轻度甲亢水平,计划分娩前2～3周停药。妊娠合并甲亢的孕妇在医生指导下合理用药一般能平稳度过孕期和分娩期,对母儿无不良影响。
Subjects for our hospital from January 1984 to October 1998 admitted 26 cases of pregnancy with hyperthyroidism patients, according to clinical manifestations and TT_4 levels were divided into mild, moderate and severe. Slightly under the doctor’s close monitoring of anti-thyroid drugs; moderate and above were given anti-thyroid drug treatment. When the condition is controlled, it is gradually reduced to 1/3 ~ 1/2 decrease every 1 ~ 2 weeks until the minimum dose of control symptom is maintained, so that the pregnant woman is in a mild hyperthyroidism level, and plans to stop 2 to 3 weeks before delivery medicine. Pregnant women with hyperthyroidism in pregnancy under the guidance of a doctor under the guidance of a rational medication can generally be passed through the pregnancy and childbirth, no adverse effects on the mother and child.